Weiwei Zhu, MS
“I have a longstanding interest in using biostatistics to advance medical research. Working at KPWHRI gives me a great opportunity to contribute to challenging projects with rich, relevant data and make a national impact on health care systems.”
Weiwei Zhu, MS
Biostatistician III, Kaiser Permanente Washington Health Research Institute
Weiwei.Zhu@kp.org
206-442-5215
Biography
Weiwei Zhu, MS, joined Kaiser Permanente Washington Health Research Institute's Biostatistics Unit in 2009. She works closely with Senior Investigator Diana Miglioretti, PhD, to design studies, manage data, and conduct statistical analyses for the Breast Cancer Surveillance Consortium (BCSC)—the National Cancer Institute’s seven-site network of mammography researchers. She has been a key member of the BCSC Statistical Coordinating Center for almost 10 years. Her work studying the breast screening benefits and risks played an essential role in an American Cancer Society screening guideline change in 2015.
Ms. Zhu also works with Senior Investigator Denise Boudreau, PhD, to quantify the serious risks of misuse, abuse, and addiction associated with long-term opioid use. This multi-site study will use electronic health record data and survey interviews to provide estimates of long-term opioid use risks in two cohorts.
After beginning her medical research career as an intern at the University of Texas MD Anderson Cancer Center in 2007, Ms. Zhu served as a biostatistician at the Moffitt Cancer Center and Research Institute in Florida.
Research interests and experience
-
Biostatistics
Correlated data analysis; longitudinal data; survival analysis
Medication Use & Patient Safety
Opioid misuse, abuse, and addiction
-
Cancer
Biostatistics; breast cancer screening and surveillance
Recent publications
Braithwaite D, Zhu W, Hubbard R, O'Meara ES, Miglioretti DL, Geller B, Dittus K, Wernli K, Moore D, Kerlikowske K, for the Breast Cancer Surveillance Consortium. Benefits and harms of screening mammography frequency by age and comorbidity score. Cancer Epidemiol Biomarkers Prev. 2012;21(3):565. Epub 2012 Feb 15. PubMed
Finkelstein S, Trotti A, Rao N, Reintgen D, Cruse W, Feun L, Sondak V, Yu D, Zhu W, Gwede C, DeConti R. The Florida Melanoma Trial I: a prospective multicenter phase I/II trial of postoperative hypofractionated adjuvant radiotherapy with concurrent interferon-alfa-2b in the treatment of advanced stage III melanoma with long-term toxicity follow-up. ISRN Immunology. 2012;2012:[10 p.]. doi:10.5402/2012/324235.
Hubbard RA, Kerlikowske K, Flowers CI, Yankaskas BC, Zhu W, Miglioretti DL. Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study. Ann Intern Med. 2011;155(8):481-92. PubMed
Bello C, Yu D, Komrokji RS, Zhu W, Wetzstein GA, List AF, Lancet JE. Outcomes after induction chemotherapy in patients with acute myeloid leukemia arising from myelodysplastic syndrome. Cancer. 2011 Apr 1;117(7):1463-9. doi: 10.1002/cncr.25598. Epub 2010 Nov 8. PubMed
Kharfan-Dabaja MA, Chavez JC, Yu D, Zhu W, Fernandez-Vertiz EI, Perkins J, Shapiro J, Bookout R, Perez L, Fernandez HF, Komrokji RS, Lancetf J, Brand L, Field T, Ayala E, Janssen W, List AF, Anasetti C. Severe hypoalbuminemia at day 90 predicts worse non-relapse mortality and overall survival after allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia and myelodysplastic syndrome. Biol Blood Marrow Transplant. 2011 Mar;17(3):384-93. Epub 2010 Jul 22. PubMed
Cancer screening
Breast density is a risk factor for older women, too
Findings in JAMA Network Open could help guide decision-making about breast cancer screening for women 75 and older.
Research
Phone therapy for insomnia shown to improve sleep
A study among KP members with sleep problems and osteoarthritis shows promise for overcoming obstacles to treatment.
News
Race, income, education affect access to 3D mammography
The technology’s potential benefits to detect breast cancer earlier are not equally shared among all women, researchers find.
Land Acknowledgment
Our Seattle offices sit on the occupied land of the Duwamish and by the shared waters of the Coast Salish people, who have been here thousands of years and remain. Learn about practicing land acknowledgment.